Morpholino

MO1-mir126

ID

ZDB-MRPHLNO-090112-4

Name

MO1-mir126

Previous Names

dre-miR-126 MO-1 (1)
MOMB (1)

Targets

mir126a (1)
mir126b (1)

Sequence

5' - TGCATTATTACTCACGGTACGAGTTTGAGTC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-mir126

Expressed Gene	Anatomy	Figures
mpl	nucleate erythrocyte thrombocyte	Fig. 4 from Grabher et al., 2011
myb	whole organism	Fig. 3 from Grabher et al., 2011
slc4a1a	nucleate erythrocyte thrombocyte	Fig. 4 from Grabher et al., 2011

Phenotype

Phenotype resulting from MO1-mir126

No data available

Phenotype of all Fish created by or utilizing MO1-mir126

Phenotype	Fish	Conditions	Figures
nucleate erythrocyte increased amount, abnormal	AB + MO1-mir126	standard conditions	Fig. 4 from Grabher et al., 2011
thrombocyte decreased amount, abnormal	AB + MO1-mir126	standard conditions	Fig. 4 from Grabher et al., 2011
brain hemorrhagic, abnormal	WT + MO1-mir126	standard conditions	Fig. S7 from Kontarakis et al., 2018
thoracic duct absent, abnormal	ci1Tg + MO1-mir126	standard conditions	Fig. S6 from Kontarakis et al., 2018
thoracic duct hypoplastic, abnormal	ci1Tg + MO1-mir126	standard conditions	Fig. S6 from Kontarakis et al., 2018
aortic arch 5 absent, abnormal	la116Tg + MO1-mir126	standard conditions	Fig. 3 from Nicoli et al., 2010
thoracic duct hypoplastic, abnormal	nz101Tg + MO1-mir126	standard conditions	Fig. S5 from Kontarakis et al., 2018
thoracic duct absent, abnormal	nz101Tg + MO1-mir126	standard conditions	Fig. S5 from Kontarakis et al., 2018
aortic arch 5 absent, abnormal	la116Tg + MO1-klf2a + MO1-mir126	standard conditions	Fig. 3 from Nicoli et al., 2010
blood vessel morphogenesis disrupted, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
dorsal aorta unlumenized, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
blood decreased fluid flow, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
blood circulation disrupted, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
nucleate erythrocyte mislocalised, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
blood vasculature broken, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
posterior cardinal vein decreased width, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
cranial vasculature broken, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
pharyngeal vasculature decreased width, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
dorsal aorta decreased width, abnormal	s843Tg; sd2Tg + MO1-mir126 + MO2-mir126a	standard conditions	Fig. 3 from Fish et al., 2008
lymph vessel development disrupted, abnormal	flt4^hu4602/+; nz101Tg + MO1-mir126	standard conditions	Fig. 3 from Kontarakis et al., 2018
medial facial lymph vessel decreased length, abnormal	flt4^hu4602/+; nz101Tg + MO1-mir126	standard conditions	Fig. 3 from Kontarakis et al., 2018
lateral facial lymph vessel decreased length, abnormal	flt4^hu4602/+; nz101Tg + MO1-mir126	standard conditions	Fig. 3 from Kontarakis et al., 2018
thoracic duct absent, abnormal	flt4^hu4602/+; y1Tg + MO1-mir126	standard conditions	Fig. 3 from Kontarakis et al., 2018

Citations